| Breakdown | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 56.99B | 55.01B | 51.37B | 49.86B | 47.22B |
| Gross Profit | 17.87B | 28.71B | 24.83B | 27.03B | 25.55B |
| EBITDA | 32.14B | 32.57B | 32.82B | 31.07B | 29.63B |
| Net Income | 23.51B | 23.05B | 19.05B | 21.13B | 19.46B |
Balance Sheet | |||||
| Total Assets | 685.77B | 685.00B | 677.84B | 682.98B | 684.45B |
| Cash, Cash Equivalents and Short-Term Investments | 26.80B | 21.15B | 42.07B | 50.41B | 48.97B |
| Total Debt | 296.20B | 297.09B | 292.09B | 294.54B | 297.64B |
| Total Liabilities | 335.48B | 335.18B | 329.96B | 332.30B | 335.54B |
| Stockholders Equity | 350.30B | 349.82B | 347.87B | 350.68B | 348.91B |
Cash Flow | |||||
| Free Cash Flow | -15.97B | -4.18B | 17.63B | 23.80B | 16.17B |
| Operating Cash Flow | 34.52B | 58.80B | 36.61B | 36.17B | 27.19B |
| Investing Cash Flow | -49.91B | -59.78B | -19.59B | -12.33B | -10.80B |
| Financing Cash Flow | 8.55B | -16.14B | -24.30B | -22.45B | -13.70B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥148.41B | 15.62 | ― | 6.26% | 55.69% | 24.75% | |
69 Neutral | ¥859.41B | 24.15 | 6.59% | 3.83% | -1.97% | -2.16% | |
66 Neutral | ¥1.21T | 28.58 | 5.94% | 3.40% | -7.30% | 7.83% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | ¥242.50B | 20.08 | ― | 4.63% | -5.47% | 14.66% | |
63 Neutral | ¥554.21B | 23.24 | ― | 4.10% | -31.88% | 2.02% | |
62 Neutral | ¥325.29B | 11.71 | ― | 3.94% | 19.18% | -23.37% |